At the mean time, slight but significant correlation between immunoreactivity of IL-17 F and the numbers of CD3+ T lymphocytes was observed in bladder cancer, suggesting that CD3+ T lymphocytes might also be a major cellular source expressing IL-17 F. This evidence concerns the gene IL17A and urinary bladder carcinoma.